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ABSTRACT 
The concentration of cholecystokinin (CCK) and vasoactive intestinal peptide (VIP) in 
dissected cortical and subcortical areas of four rhesus monkeys’ brains was determined by 
radioimmunoassay (RIA). Cerebral cortical samples from one human brain are included 
for comparison. Preliminary data from two baboon brains are described. The results are 
similar to previous studies on rat (l-71, human (7-121, porcine (12,131, bovine (31 and 
guinea pig brains (14) and indicate that: 1) both CCK and VIP are widely distributed in 
cortical and subcortical areas in these species, 2) CCY is generally more abundant than 
VIP in primate brain, and 3) the distribution of CCK and VIP in the rat brain parallel those 
in infrahuman primate and human brain. 
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INTRODUCTION 
CCK (15) and VIP (16), originally discovered as gastrointestinal hormones, both have a 
wide distribution in the mammalian central nervous system and occur in particularly high 
concentrations in cerebral cortex (l-14,17). Both have been localized in separate groups 
of specific cells in cerebral cortex which have an intimate association with cerebral blood 
vessels (17,18). It has been suggested that these peptides may in some way regulate 
cerebral blood flow (17,18). 
The distributions of CCK and VIP have been studied in detail in many mammalian 
species including man using both RIA and immunocytochemistry. There are no data, 
however, on the distribution by RIA of either CCK or VIP in the brains of infrahuman 
primates. The data presented in this paper on CCK and VIP levels in rhesus monkey brain 
are intended to fill this gap, and to provide data to compare with previous studies on 
post-mortem human brain (7-9). 
METHODS 
A. Tissue dissection and extraction: 
Rhesus monkey brains were obtained and dissected as in Lewis e al. (19). The 
samples were frozen after dissection, stored at -70°C, homogenized in 10 volumes of ice 
cold O.IN HCI and clarified by centrifugation. Ten u1 aliquots of the supernatant were 
lyophilized prior to the VIP RIA. Prior to the CCK RIA, the 10 1-11 aliquots were 
neutralized with 10 ul of O.IN NaOH. 
The human cerebral cortical samples were obtained from Massachusetts General 
Hospital, courtesy of Tricia Marshall. The frozen tissue was homogenized at room 
temperature in methanol:water 9:l (v/v), centrifuged, and the methanol supernatant 
evaporated under nitrogen. 
B. CCK and VIP radioimmunoassay: 
The CCK RIA was performed with antiserum R5 as previously described (2). This 
CCK antiserum cross-reacts strongly with CCKS sulfate, CCK33, gastrin and caerulein 
and weakly with CCKS desulfate and CCK4. The exact chemical nature of the CCK-like 
peptides in rhesus monkey brain has not been established. On the basis of gel filtration 
chromate raphy and CCK RIA, human cerebral cortex contains mainly CCKS-like 
peptides s Reference 12 and M. Beinfeld, unpublished observations). The VIP RIA was 
performed as previously described (20) using a VIP antiserum provided by Cajanan Nilaver. 
This antisera did not cross-react with secretin, GIP (gastric inhibitory peptide), glucagon, 
and only about 0.02% with PHI (acronym for a Peptide with a C-terminal Histidine and an 
N-terminal Isoleucine amide). 
RESULTS 
The CCK and VIP concentrations in cerebral cortical regions of the rhesus monkey 
brain are shown in Table 1. These samples were dissected as described before (191, based 
on the cytoarchitectonic map of von Bonin and Bailey (21). The CCK levels in all regions 
of the rhesus monkey cerebral cortex are high. In the rhesus monkey, the frontal and 
orbital regions are higher than the motor and sensory, parietal and occipital regions. A 
similar rostro-caudal gradient has been reported in the human brain (8). Table 2 presents 
data on the CCK levels in three cerebral cortical areas from one human brain for 
comparison with the rhesus monkey data. The data in Table 2 on CCK content of human 
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cortex agree very well with the rhesus monkey data, and, though it is unsafe to generalize 
from a single sample, there appears to be a marked rostro-caudal gradient in CCK 
concentration in the cortex of this individual. 
Table I: CCK and VIP concentrations in cortical areas of the rhesus monkey brain 
Cytoarchitectonic CCK VIP 
Area Designation (pg/mg tissue) (pg/mg tissue) 
Inferior prefrontal FD/FDy 
Midlateral prefrontal FD 
Dorsal prefrontal FD 
Medial prefrontal FD 
Midorbital prefrontal FD 
Medial orbital FL 
Posterior orbital FF 
Olfactory tubercle FF 
Prearcuate FDA 
Dorsal premotor F0lFC 
Ventral premotor FCBm 
Frontal operculum FCop 
Anterodorsal motor strip ant. FA 
Precentral post. FA/FBA 
Postcentral PB/PC 
Superior parietal PE/PEm 
Inf. parietal ant. PF 
Inf. parietal, post. PC 
Parietal operculum PF/PCop 
Cingulate, anterior LA 
Cingulate, posterior LC 
Supratemporal plane TC/TB 
Superior temporal, post. TA 
Superior temporal, ant. TA 
Temporal pole, dorsal dor. TG 
Infer. temporal, post. TEO 
Infer. temporal, ant. TE 
Temporal pole vent. vent. TG 
Periamygdaloid A 
Entorhinal ant. TH 
Parahippocampal post. TH 
Fusiform TF 
Insular, ant. IA 
Insular, post. IB 
Preoccipital, lat. lat. OA 
Preoccipital, med. med. OA 
Peristriate, lat lat. OB 
Peristriate, med. med. OB 
Striate, lat. lat. OC 
258 f 16 
311 f 46 
356 ?: 86 
458 + 109 
205 f 42 
394 f 85 
369 (338, 399) 
327 (271, 383) 
217 f 40 
316 + if 1N=3) 
254 f 43 (N=3) 
234 f 60 
268 (260, 276) 
144 + 49 
169 f 37 
357 + 69 (N=3) 
222 f 23 (N=3) 
213 + 48 
237 f 69 
372 + 32 (N=3) 
225 f 72 
252 f 25 (N=3) 
226 f 51 (N=3) 
209 + 18 (N=7) 
247 f 21 (N=3) 
174 ?r 40 (N=3) 
177 + 29 (N=lO) 
244 + 34 (N=3) 
354 (261, 446) 
232 (189, 274) 
341 (337, 344) 
274 + 41 
268 (224, 331) 
160 (118, 199) 
201 + 21 (~=8) 
254 f 32 (N=8) 
190 f 20 (~=8) 
108 (99, 117) 
197 f 16 fN=3) 
100 f 4 
111 k 14 
93 * 12 
86 f 9 
92 rt 11 
112 f 22 
104 (80, 128) 
64 (63, 64) 
95 ? 9 
75 + 12 
102 f 19 
104 f 17 
72 (72) 
82 + 18 
96 t 8 
113 + 10 
120 f 11 
112 f 1 
96 f 16 
96 f 11 
105 + 16 
89 k 19 
78 (74, 81) 
102 f 12 
90 2 16 

























Striate, med. med. OC 123 f 26 68 f 13 
The number of samples of the same region included in the average and standard error of 
the mean is four (4) except when indicated. 
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Table 2: CCK Concentration in Human Frontal, Temporal, and Occipital Cortex 
CCK 
Brain Region pg/mg tissue N 
Frontal 340.2 f 39.8 4 
Temporal 291.3 + 23.3 4 
Occipital 152.4 * 23.5 4 
Four samples of each cortical area from one 57 year old male taken 8 l/2 hours 
post-mortem. The samples were extracted in 90% methanol as previously described (2). 
In the rhesus monkey cortex, there is about 5-20 times as much CCK as VIP on a 
molar basis. The areas that are highest in CCK are not highest in VIP though they are 
both present in all cortical areas examined, their distributions are not correlated. 
Some cerebral cortical areas obtained from two baboon brains were assayed for 
CCK and VIP content (data not shown). Though the dissection differed from that used for 
the rhesus brains and the sample sizes were smaller, some comparisons can be made. In 
the baboon cerebral cortex, the CCK : VIP molar ratio is about 2-6 and, like the rhesus, 
there is no correlation between the distributions of CCK and VIP. In most of the cortical 
areas examined, the rhesus and baboon levels of CCK were the same within experimental 
error. 
Two interesting trends can be observed in the distribution of CCK in the rhesus 
monkey cortex. The CCK levels tend to be less than 200 rig/g in the motor and sensory 
processing areas: pre- and post-central, inferior temporal, posterior insular, striate and 
peristriate cortices. The CCK levels tend to be greater than 300 nglg in the cortical 
areas which receive projections from the magnocellular portion of the nucleus medialis 
dorsalis of the thalamus: medial prefrontal, medial and posterior orbital and anterior 
cingulate cortices. The possible functional significance of this observation remains to be 
determined. 
The VIP concentration is high in all rhesus monkey cortical regions. Unlike CCK, 
there appears to be no rostro-caudal gradient of VIP. Unlike CCK, most of the baboon 
cortical samples had higher levels of VIP (at most a factor of two) than the corresponding 
areas in the rhesus monkey. 
Table 3: CCK and VIP concentrations in subcortical areas of the rhesus monkey brain 
CCK VIP Cont. 
Area pglmg tissue pglmg tissue 
Caudate 126 f 52 (N=3) 17 + 3 
Septum 131 (131) 41 (41) 
Olfactory bulb 108 (35.5, 180) 
Inferior colliculus 107 (80, 133) 49 (48, 50) 
Superior colliculus 32 (11.3, 52) 46 (46, 46) 
Putamen 80 * 12 13 + 4 
Hypothalamus anterior 74 (74) 59 (58, 59) 
Thalamus (nut. med. dors.) 21 (7.3, 34.4) 19 (15, 22) 
Cerebellum 19 + 2 7 +2 
Clobus pallidus 16 (15, 16) 18 f 2 
The number of samples of the same region included in the average and standard error of 
the mean is four (41 except when indicated. 
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The CCK and VIP concentrations in subcortical regions of the rhesus monkey 
brain are shown in Table 3. As in the cerebral cortex, CCK is higher than VIP on a molar 
basis in the subcortical regions. The CCK content in the baboon subcortical areas was 
higher than the rhesus in the caudate, hypothalamus, putamen, globus pallidus, while the 
colliculi and the thalamus were the same. 
In the baboon, the VIP level in caudate and putamen was higher than in rhesus 
monkey while in hypothalamus, thalamus and colliculi, the VIP levels are similar. As in 
the rat (5,6), the baboon amygdaia is high in VIP, similar to cerebral cortical levels. 
DISCUSSION 
This study was conducted to provide information on the distributions of CCK and 
VIP in the primate brain obtained under controlled conditions with a minimum post- 
morten time prior to dissection and storage. The most striking aspect of the distribution 
of CCK and VIP in infrahuman primate brain is the very high concentration of both 
peptides throughout the cerebral cortex. This finding is in agreement with the results of 
previous investigations in a variety of other species, and points to a particularly important 
role of VIP and CCK in cortical function, such that high cortical levels of these peptides 
is conserved across species. 
The distribution of CCK in human brain has been examined in detail by RIA 
(8-l I). In one study, where CCK was only measured in the temporal lobe (II), levels of 
CCK were the same as the rhesus. In another report by Ceola et al. (91, human CCK 
levels were much lower than we 
cortex vs 205-458 q/g for rhesus). 
found in the rhesus E2y;;g/g for frontal 
The most detailed study of the distribution of CCK in 
the human brain by Emson et al. (8) showed consistently higher values for cortical and 
subcortical CCK in the human than the rhesus (419-1178 nglg vs 205-458 ng/g). The study 
of Vanderhaeghen (71, however, gives the best agreement with rhesus data except in the 
caudate and thalamus where Vanderhaeghen’s values are lower than the rhesus. The 
agreement between the human and rhesus values for CCK, even though the mean autopsy 
time in the Emson study (8) was 50 hours and the Vanderhaeghen study (7) was 24 hours, 
demonstrates that CCK immunoreactivity is very stable post-mortem. 
The distribution and levels of CCK appear to be well conserved in mammalian 
species. The rat and guinea pig (l-3,14) CCK levels closely resemble rhesus , except 
that both rat and guinea pig have more CCK in the caudate and thalamus, while the CCK 
in the rat cortex and hypothalamus is higher than in the rhesus monkey. Likewise, pig 
brain is higher in most areas in CCK than the rhesus monkey while cow brain is the same 
or lower. 
The distribution of VIP in human brain has been less extensively studied than the 
CCK distribution. The data of Samson et al. (10) best resembles the rhesus monkey data, 
although several of the cortical areas zbthe caudate were higher in VIP in the rhesus 
monkey than in the human. The human VIP data of Fahrenkrug (22) also agrees well with 
the rhesus VIP values in some cortical areas, the caudate, and hypothalamus, although 
most of the cortical areas have lower VIP than the rhesus. 
The VIP data of Bryant (4) is consistently lower for human cortex, while VIP 
levels in human hypothalamus is similar to rhesus. 
Like CCK, the distribution of VIP also is well 
mammalian species. In comparison to rhesus monkey or 
subcortical areas are substantially lower in VIP (13). Rat 
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conserved in the brains of 
rat, pig brain cortical and 
brain VIP, both in terms of 
distribution and levels, is quite similar to rhesus monkey subcortical VIP levels, while the 
rat cortex is consistently higher in VIP than the cortex of rhesus monkey. These 
differences in VIP and CCK levels reported from different laboratories may be due to 
differences in extraction, storage or the use of peptide antisera with different antigenic 
determinants. The fact that our human and rhesus monkey data for CCK are so similar, 
despite the use of different extraction methods (though the CCK antiserum was the 
same), indicates that antiserum differences between laboratories may account for the 
discrepant values. An additional potential problem with comparison of VIP data between 
laboratories is the possibility that the VIP antisera used in these orevious studies cross- 
reacts with other newly discovered members of the VIP family of peptides such as 
secretin (23) or PHI (241, recently detected in mammalian brain. 
In comparing the CCK and VIP levels in the brain regions of different 
mammalian species, some differences do appear and may reflect real species differences 
in brain VIP and CCK concentration. To examine this properly, however, a comparative 
study should be done in the same laboratory using the same methods of storage, 
extraction, RIA, etc. 
What is very clear from the comparison that of 
comes the closest to infrahuman primate and human brain 
both VIP and CCK levels, and their relative distribution. 
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